Dendritic cells (DCs) serve as a link between the innate and adaptive immune systems. The activation state of DCs is crucial in this role. However, when DCs are isolated from lymphoid tissues, purified and placed in culture they undergo 'spontaneous' activation. The basis of this was explored, using up-regulation of DC surface MHC II, CD40, CD80 and CD86 as indicators of DC activation. No evidence was found for DC damage during isolation or for microbial products causing the activation. The culture activation of spleen DCs differed from that of Langerhans cells when released from E-cadherin-mediated adhesions, since E-cadherin was not detected and activation still occurred with b-catenin null DCs. Much of the activation could be attributed to DC-DC interactions. Although increases in surface MHC II levels occurred under all culture conditions tested, the increase in expression of CD40, CD80 and CD86 was much less under culture conditions where such interactions were minimised. DC-to-DC contact under the artificial conditions of high DC concentration in culture induced the production of soluble factors and these, in turn, induced the up-regulation of co-stimulatory molecules on the DC surface.
INTRODUCTION
Dendritic cells (DCs) are often considered as the essential link between the innate and adaptive immune systems. The activation state of DCs is a crucial issue in determining this biological function. 'Immature' or 'quiescent' DCs actively take up and process antigens, but are relatively poor stimulators of T-cells. After 'maturation' or 'activation' by microbial stimuli, inflammatory cytokines or tissue damage, DCs lose the ability to present newly encountered antigens but become efficient stimulators of T-cells, 1,2 thus initiating adaptive immune responses. Maturation or activation is accompanied by an increase in the surface expression of major histocompatability complex (MHC) II and co-stimulator molecules. [1] [2] [3] [4] [5] This shift in surface phenotype upon stimulation had been considered to correspond to a change in the DC from a tolerogenic to an immunogenic status. [6] [7] [8] [9] [10] [11] However, a form of partial activation may be required even for a DC to be tolerogenic. 12, 13 In addition, the mature DCs that arrive in lymph nodes from peripheral tissues in steady state are likely to be tolerogenic. Thus a 'mature' surface phenotype alone does not define an immunogenic DC and additional signals are needed to drive a DC to cytokine production and to an immunogenic state. 14 Studies from this laboratory have demonstrated that non-migratory, lymphoid tissue resident DCs of steadystate, non-infected laboratory mice are in what can be considered an immature state. 15 Although such DCs do express some surface MHC II and co-stimulator molecules, this is well below the level in an activated state. 15 Antigen processing by such DCs is that of immature cells and they are still capable of antigen uptake by phagocytosis or endocytosis. One technical problem that limits our capacity to study the developmental state and immunological function of such steady-state DCs is that, on isolation and culture, they 'spontaneously mature' or 'spontaneously activate', with up-regulation of surface MHC II and co-stimulatory molecules. 5, 15, 16 As a result of this maturation or activation process, the DCs show an enhanced ability to activate T-cells in response to antigens they already present, but show a much reduced capacity to capture, process and present antigens introduced after the culture period. 15 However, such cultureactivated DCs differ from DCs activated by microbial stimuli, since they do not produce cytokines such as bioactive interleukin (IL)-12p70; this requires additional activation signals, generally from microbial products interacting with Toll-like receptors (TLRs). 17, 18 Thus, when DCs freshly isolated from spleen are used to stimulate T-cells in culture, the DCs might already be partially activated by the time they make effective interaction with the T-cells, complicating the interpretation of the results obtained. Understanding the basis of this spontaneous activation process may help overcome this technical hurdle and might also provide some clues to the factors that normally regulate the activation state of DCs in vivo. In this study, we investigate the basis of the spontaneous activation of purified spleen DCs in culture, systematically eliminating many factors suggested in the past, and introducing a new model of DC-to-DC self activation.
MATERIALS AND METHODS

Mice
Mice were bred at the Walter and Eliza Hall Institute under specific pathogen-free (SPF) conditions unless otherwise stated. For most experiments, 5-7-week old female C57BL/6 J Wehi mice (CD45.2) were used. C57BL/6Pep 3b Ly5.1(CD45.1) mice were also used in experiments to distinguish fixed from normal DCs. Of the mutant mice in a C57BL/6 background, the rag1 null mice were obtained from L. Corcorcan, 19 the il7r null mice 20 from Jackson Laboratories (Bar Harbour, Maine, USA) and the myd88 null mice from S. Akira. 21 The ifnar1 null and ifnar2 null mice and background 129 strain mice were bred under SPF conditions at the Monash Medical Centre. The generation and description of the mice lacking the interferon (IFN)-a receptor 1 has been described; 22 the mice lacking transmembrane and soluble isoforms of the IFN-a receptor 2 were generated by targeting exon 4 of the ifnar2 gene (Hertzog et al., unpublished). All experiments involving mice were approved by the Walter and Eliza Hall Institute Animal Ethics Committee.
Bone marrow chimeric -catenin deficient mice
These mice were constructed at the Ludwig Institute (Lausanne, Switzerland) as described in detail previously, 23 and approved by the Service Veterinaire Cantonal of Etat de Vaud. Briefly, the bone marrow donor mice, both the test b-catenin lox/lox Mx-Cre þ/mice and the control b-catenin lox/lox mice, were given a schedule of polyI-polyC injections which caused complete deletion of the b-catenin gene in the test bone marrow, as verified by Southern blot analysis. T-Cell depleted bone marrow (5 Â 10 6 cells) from the test or control CD45.2 donors was injected into 10-week-old lethally irradiated (1000 cGy) B6.SJL-Ptprca CD45.1 mice. The spleens of the recipient chimeric mice were harvested for DC isolation 6 weeks later. On subsequent staining and flow-cytometric analysis, the DCs were gated so the minority of recipient CD45.1 cells were excluded and the donor type CD45.2 cells analysed. A total of 12 b-catenin deficient and 12 control chimeric mice were generated.
Dendritic cell isolation
The standard procedure for isolation of conventional DCs free of plasmacytoid DCs was based on our earlier procedures. 16, 24, 25 This was used unless otherwise stated. All media were at pH 7.2 and iso-osmotic with mouse serum (308 mOs). Eight spleens were cut into small fragments and digested with frequent mixing for 20 min at room temperature (22 C) in 7 ml modified RPMI-1640 medium þ 2% fetal bovine serum (FCS) containing collagenase (1 mg/ml; Worthington Biochemical, Freehold, NJ, USA; verified free of trypsin-like protease activity) and DNAase I (0.02 mg/ml; Boehringer Mannheim, Mannheim, Germany). An EDTA solution (600 ml, 0.1 M, pH 7.2) was then added and mixing continued for 5 min. Undigested material was removed by filtration through a coarse sieve. All subsequent steps were at 0-4 C, using a divalent metal free buffered balanced salt solution containing EDTA (EDTA-BSS). Cells from the digest were centrifuged to a pellet and the pellet resuspended in 10 ml of a 1.077 g/cm 3 medium, made by dissolving Nycodenz powder (Nycomed, Oslo, Norway) in water as a dense stock (0.37 M) then diluting in EDTA-BSS to give the required density at 308 mOs. Further Nycodenz was layered below the Nycodenz cell suspension, EDTA-FCS layered above, then the tube centrifuged at 1700 g for 10 min. The light density fraction (51.077 g/cm 3 ) was collected, diluted in EDTA-BSS, recovered by centrifugation, then incubated for 30 min with the following monoclonal antibodies (mAbs): anti-CD3 (KT3-1.1); anti-Thy1 (T24/31.7); anti-B220 (RA3-6B2) anti-Gr1 (RB68C5); and antierythrocyte (TER-119). All mAbs were titrated and used at near saturation conditions except anti-Thy1, which was used at 25% saturation. The cells were washed free of excess mAbs, then antibody-coated cells removed using anti-rat Ig coupled Biomag beads (Qiagen, Clifton Hill, Australia). The beads and cells at a 10 : 1 ratio were mixed as a concentrated slurry by slow rotation for 20 min, diluted with EDTA-BSS, then the beads and bound cells removed with a magnet, using two removal steps. The spleen dendritic cells (70-80% pure) were suspended in EDTA-BSS for staining and sorting. The mAb, the fluorescent conjugates, the labelling and sorting procedures were all as described previously. 16, 24 To prepare the total DCs, the cells were labelled with anti-CD11c (N418) used as a FITC conjugate, including propidium iodide (1 mg/ml) in the final wash to label dead cells. The cells showing high fluorescence for CD11c were selected, gating out dead cells, autofluorescent cells and doublets, and sorting on a DIVA instrument (Becton-Dickinson, San Jose, CA, USA). In some experiments, where indicated, any possible residual natural killer (NK)-like cells in the DC preparations were eliminated by staining with mAb against CD49b (DX5) and gating out any positively staining cells. 25 To select out the three subtypes of spleen conventional DCs, the cells were additionally stained with anti-CD8a (YTS 169.4) as an allophycocyanin (APC) conjugate and anti-CD4 (GK1.5) as an Alexa 594 conjugate; the gated CD11c high cells were then sorted into CD4 þ CD8and CD4 -CD8 þ and CD4 -CD8subtypes. 24 Sorted cells were recovered, counted and suspended in RPMI-1640/FCS culture medium.
Standard dendritic cell incubation procedure
The incubation medium, unless otherwise stated, was a modified RPMI-1640 medium with additional HEPES buffering, iso-osmotic with mouse serum (308 mOs), and containing 10% FCS. Incubation was normally overnight (18 h) at 37 C in a 10% CO 2 -in-air incubator. Dendritic cells were normally cultured at high density (5 Â 10 6 cells/ml), but where specified at low density (2 Â 10 5 cells/ml), in a total volume of 1 ml, in flat-bottomed wells of a 24-well tissue culture plate (Becton Dickinson, Franklin Lakes, NJ, USA). Costar Ultra Low Attachment culture plates (Corning, NY, USA) were also used where indicated.
Staining and analysis of dendritic cells before and after culture
Samples of the DCs prior to culture and the DCs post culture were normally stained to identify DCs with anti-CD11c (N418 conjugated to phycoerythrin) and to determine the activation status with either anti-MHC II (M5/ 1114) or anti-CD40 (FGK45.5) or anti-CD80 (16-10.A1) or anti-CD86 (GL1), all as fluoroscein isothiocyanate conjugates. Propidium iodide (PI) was included at 10 mg/ml in the final wash to distinguish dead cells. Samples were normally run on a FACScan (Becton Dickinson) and the PI-negative CD11c-positive cells analysed using WEASEL software. For the DCs from chimeric mice, the samples were additionally stained to identify donor from host cells with anti-CD45.1 (A20 conjugated to PE Cy7) and anti-CD45.2 (104 conjugated to APC), and analysed on a FACSCanto (Becton Dickinson).
Dendritic cell incubation in semi-solid media
Medium containing 3% methylcellulose (Methocel 65 HG; Fluka Biochemika) was prepared by adding the methylcellulose to boiling water, cooling, then diluting 2-fold with twice concentrated RPMI-1640 with 20% FCS. Complete solubilisation was achieved by stirring at 4 C overnight then freezing. The DCs were suspended in this medium then cultured 18 h. Dendritic cells were recovered by centrifugation, then analysed. In some experiments, a 3-D collagen culture system (Chemicon International, Temecula, CA, USA) was used as an alternative, following the manufacturer's instructions, with collagenase used to harvest the DCs.
Effects of dense spleen cells, T-cells and B-cells
Dense cells from spleen were collected by recovering and washing the pellet from the 1.077 g/cm 3 Nycodenz density cut used to concentrate DCs. The dense cells were then depleted of either B-cells, T-cells or both. B-Cells were coated with an anti-CD19 monoclonal antibody (1D3), T-cells using an anti-CD3 monoclonal antibody (KT3-1.1) and depleted using sheep anti-rat Ig coated Dynabeads (Dynal, Oslo, Norway). The dense spleen cells at 175 Â 10 6 cells/ml, or the cells obtained after depletion of this number, were added back to purified DCs (5 Â 10 6 cells/ml) then cultured under the standard conditions.
Effects of soluble factors produced by spleen cells
Spleen cells (20 Â 10 6 cells/ml) were cultured in RPMI-1640 þ 10% FCS medium overnight and the supernatant collected. Dendritic cells (5 Â 10 6 cells/ml) were then cultured overnight in 10%, 20%, 50% or 100% of the spleen cell supernatant. Alternatively, spleen cells from one spleen or half a spleen in 300 ml medium were placed in 0.1 mM cell culture inserts (Becton Dickinson). The inserts were placed in the wells of 24-well plates containing 500 ml medium and incubated at 37 C for 3 h. The DCs (5 Â 10 6 cells in 500 ml medium) were then added to the external well and cultured overnight.
Fixed dendritic cells
Dendritic cells from CD45.2 mice were fixed with 4% paraformaldehyde in PBS for 10 min, then washed three times. The fixed CD45.2 DCs at 5 Â 10 6 cells/ml were cultured with normal DCs from CD45.1 mice at 2 Â 10 5 cells/ml. On subsequent staining and flow cytometry, the cells were gated so the viable CD45.1 þ DCs were analysed.
Soluble factors from DC-DC interactions
Dendritic cells were cultured at 5 Â 10 6 cells/ml in standard medium overnight and the supernatant was collected. Fresh DCs were then cultured overnight at 2 Â 10 5 cells/ml in 50% culture supernatant/50% fresh medium.
RESULTS
Initial activation status of isolated dendritic cells
The surface levels of MHC II, CD40, CD80 and CD86 were chosen as convenient indicators of the activation or maturation status of the splenic conventional DCs. These markers are known to increase following overnight incubation of DCs in culture, roughly in parallel with a decrease in ability to take up and process exogenous antigens and an increase in ability to present processed antigens and activate T-cells. 15, 16 It was important to establish the starting levels of these markers on the surface of isolated DCs. In particular, we wished to determine if the DCs had already been subjected to microbial stimuli before isolation. In addition, we asked if the process of digestion of spleen tissue with collagenase for 25 min at room temperature (22 C), or the pressure and shear forces associated with cell sorting, had caused or initiated DC activation.
The results shown in Figure 1 indicate that freshly isolated spleen conventional DCs already had a substantial level of surface MHC II and already had clearly detectable, if relatively low, levels of CD40, CD80 and CD86. There was no difference in the levels of any of these markers on freshly isolated DCs between germ-free mice and our standard SPF laboratory mice, suggesting these initial levels were not induced by microbial stimuli. Importantly, there was no difference between the levels on DCs isolated by our standard chopping then collagenase digestion procedure compared to DCs isolated (with reduced yield) by mechanical disruption of the spleen, where the DCs were maintained at 0-4 C from the moment the spleens were removed from the mice. Thus, the brief incubation at 22 C during collagenase digestion had not caused immediate expression of these markers on isolated DCs. In addition, we compared the level of these markers in the DC preparation prior to sorting (70-80% pure) with the post sorting DCs (99% pure); no differences were seen (data not shown). The surface level of these indicator markers was, therefore, assumed to be a good reflection of the status of the DCs in vivo. All these markers showed a consistent and statistically significant (P50.0001) increase in modal fluorescence on overnight culture ( Fig. 1 ).
Dependence of marker up-regulation on transcription, translation and export systems
To determine how much of the DC cellular machinery needed to be activated to increase surface expression of the markers used, inhibitors of RNA synthesis (actinomycin D), protein synthesis (cyclohexamide) and transport to the cell surface (brefeldin A) were added to the cultures of freshly isolated spleen DCs. Since these caused cell death over longer incubation periods, the culture time was restricted to 3 h. All three inhibitors prevented the increases seen over this short time in the expression of all four markers ( Fig. 2A ). The increases in these markers, therefore, reflected activation events extending back to the gene transcription level.
Up-regulation of markers on different DC subsets on culture
Spleen contains three distinct subtypes of conventional DC, separable as CD4 þ CD8 -, CD4 -CD8and CD4 -CD8 þ DCs. 8, 24 When freshly isolated, they expressed similar levels of MHC II, CD40 and CD80, but the CD4 -CD8 þ DCs expressed slightly higher levels of CD86. It was important to determine if all subsets were susceptible to spontaneous activation in culture, if it occurred when a single DC subtype was incubated alone, and if there were differences between subtypes in the rate of the process. As shown in Figure 2B , all three DC subtypes displayed up-regulation of all four surface markers in culture, although it was more rapid and achieved higher levels for the CD4 -CD8 þ subtype. Changes in surface levels were detected as early as 3 h, although variable at this time point, and continued over the whole 18 h period tested. In separate experiments, we also confirmed our earlier published findings 15, 17, 26 that the ability to take up and present ovalbumin antigen to ovalbumin-specific T-cells had dropped markedly in each DC subset after 18 h of culture, and that no level of the cytokines IL-12p70, IL-6, IFN-a or IFN-g detectable by ELISA assay was produced by any DC subset after 18 h or after 3 d of culture in simple medium. As a result of these findings, the sorted CD11c hi DC preparation containing all three DC subtypes was used in most subsequent experiments, and the level of markers was determined after 18 h of culture. Between 60-70% of the input DCs survived as viable cells at this time.
Influence of lymphoid cells on initial levels and up-regulation of indicator markers
To determine if the presence of lymphocytes had induced the initial expression of the surface markers or had triggered in vivo a capacity to up-regulate these markers on subsequent culture, the total DCs from the lymphoid cell deficient RAG-1 null mice 19 and the partially lymphoid deficient IL-7R null mice 20 were examined. In both cases, near normal initial levels of cell markers were seen, although MHC II was lower and CD80 and CD86 marginally higher in the DCs from RAG-1 null mice ( Fig. 3 ). However, in both cases, upregulation of all markers occurred normally in culture.
Does the isolation procedure induce DC activation in culture?
The DCs isolated by our standard brief collagenase digestion procedure and by the simpler mechanical disruption procedure carried out in the cold, both showed substantial up-regulation of the markers on subsequent culture, indicating that the collagenase digestion procedure had not caused the subsequent activation process (Fig. 1 ). The extent of up-regulation of co-stimulator molecules by DCs prepared by collagenase digestion appeared to be a little higher than by DCs prepared in the cold; however, mechanical teasing extracts less of the CD4 -CD8 þ DC subtype, which shows the most rapid increases in the markers (Fig. 2B) , so reduction in the contribution of this DC subtype could explain the slightly lower expression levels attained. DC preparations made without the use of EDTA (normally used to reduce DC clumping) gave the same level of marker up-regulation as the normal DC isolation protocol (data not shown), so the chelation of calcium or magnesium did not initiate DC activation. The DC preparation prior to sorting (which had not been surface stained for CD11c) and the purer DC preparations postsorting showed similar up-regulation of these markers in culture, indicating that neither surface labelling with mAb nor the physical stresses of sorting had induced the subsequent activation in culture (data not shown). 
Comparison of the levels of MHC II and co-stimulator molecules before and after culture of purified DCs differing in origin. Total spleen CD11c þ DCs were isolated from either germ-free mice or from our normal SPF mice ('normal'). They were released from the spleen either by our standard procedure of chopping then collagenase digestion at 22 C ('digested'), or with reduced yield by mechanically teasing the spleen apart with needles at 0-4 C ('teased'). Samples were removed for immediate analysis, the remainder being cultured for 18 h. The grey profile is the background fluorescence from stained samples lacking only the specific mAb. The vertical lines mark a peak of fluorescence for ease of comparison between profiles. One of three experiments giving identical results is shown. Elimination of any traces of residual NK-like cells by exclusion of CD49b þ cells did not alter the results (data not shown). Overall, neither these particular aspects of the DC isolation technique nor the final purity of the DC preparations determined the spontaneous activation of the DCs in culture.
Is DC activation in culture caused by microbial products?
One possible reason for DC activation in culture could be contamination with endotoxin or other microbial products. Our media were tested and found to be endotoxin free. As shown later, DC activation also occurred in the absence of serum in the culture medium.
Nevertheless, the possibility that low-level endotoxin contamination caused the activation had to be excluded. Accordingly, we checked whether there was a role for TLR signalling or related signalling pathways in the initial marker levels or the capacity to up-regulate these in culture. DCs from mice deficient in MyD88, which are unable to transmit most TLR signals, 21 were tested. However, the initial levels of the markers on DCs and their up-regulation in culture was identical with that of wild-type mice (Fig. 3 ). To rule out TLR signalling through the MyD88-independent TRIF pathway, we also examined mice deficient in the TRIF adaptor molecule, which are unable to transmit through TLR3 and TLR4. 27 The initial levels of the markers on DCs and their upregulation in culture were identical with that of wildtype mice. We had previously published results from Fig. 3 . Lack of effect of different mutations on the initial and culture up-regulated levels of MHC II and co-stimulator molecules on DCs. The total purified CD11c þ spleen conventional DCs were studied, without segregation into subsets defined by CD4 and CD8. Culture time was 18 h. Note that for the C57BL/6 background mice the anti-MHC II mAb was fluorochrome conjugated at a reduced level so fluorescence was always on scale; for the C3H/ HeJ mice, a different optimally conjugated anti-MHC II mAb was used, so staining levels appear higher. Shown are C57BL/6 results of one representative experiment. All mutant mice were compared to C57BL/6 controls in separate experiments. For all mutant mice, staining was comparable to C57BL/6 staining on the day. Each experiment was repeated twice with near identical results.
double knockout mice and initial levels of MHC II, CD40 and CD86 on DCs and their up-regulation in culture was also identical with that of wild-type mice, 28 thus ruling out the possibility of MyD88 and TRIF playing redundant roles in DC activation. The C3H/HeJ mouse strain has a TLR4 defect so responds poorly to Escherichia coli lipopolysaccharide (LPS) or endotoxin. 29 However, the initial levels of markers on C3H/ HeJ mouse spleen DCs and their up-regulation on culture seemed similar to that of the C57BL/6 mice, despite the differences in strain background and in staining intensity due to the use of different anti-MHC II mAbs (Fig. 3) .
Overall, we concluded that microbial products giving TLR signals had not induced the initial expression of these surface molecules on DCs in vivo, nor did they cause their up-regulation on culture.
Is DC activation in culture caused by uric acid?
Uric acid released from dying cells has been shown to provide a DC activation signal. 30 Since around 30% of the input DCs die in these 18 h cultures, uric acid from dead DCs might have activated the DCs which survived. We tested this by adding to the cultures various levels of allopurinol, a uric acid analogue which blocks uric acid activation of DCs. 30 However, this caused no reduction in MHC II or co-stimulator molecule up-regulation (data not shown).
Is DC activation in culture caused by adherence to the culture vessel?
One possible cause of DC activation might have been the spreading out and adhesion of the DCs to the plastic surface of the culture wells. However, in contrast to macrophages, spleen DCs showed little adherence to the surface of the wells. Furthermore, when V-wells rather than flat-bottomed wells were used to reduce the relative surface available at the vessel base, the extent of up-regulation of the markers increased rather than decreased (data not shown). Finally, when flat-bottomed culture plates with a surface coating that reduced cell adhesion were used, the extent of up-regulation increased slightly, rather than decreased (data not shown). Overall, it seemed unlikely that DC adhesion to the plastic surfaces was the basis of their activation in culture.
Are type 1 interferons involved in the up-regulation of DC surface markers in culture?
It was possible that cytokines produced by the DCs themselves could be responsible for up-regulation of the markers in culture, although for most cytokines additional microbial stimuli would be required to induce secretion. Type 1 interferons were possible candidates, since there is evidence for their priming of DCs in vivo, and of a contribution to the spontaneous activation of DCs in culture. 31 However, the major producer of type 1 interferons, the plasmacytoid cells, had been removed in our conventional DC isolation procedure. Another possibility was that type 1 interferons could precondition the DCs in vivo so they were more susceptible to activation in culture. To determine if type 1 interferons had any role, we tested DCs from mice lacking one or other of the two receptors for the major type 1 interferons. 22, 32 Dendritic cells were obtained in good yield from the spleens of these interferon receptor null mice, although the proportion of CD8 þ DCs was only 50-60% of that in the DCs isolated from the 129 control mice. The initial level of MHC II, but not of CD40, CD80 or CD86, was a little lower in the total DCs from these mice. On culture of these DCs, all markers were up-regulated, although the final level obtained was reduced a little for all the markers except CD80 (Fig.  4A ). The reduced proportion of CD8 þ DCs would explain at least part of this reduced up-regulation. Overall, type 1 interferons acting via these receptors did not appear to be responsible for initiating spontaneous DC activation on culture, although they had an influence on the levels of markers expressed.
Is DC activation caused by release from e-cadherin adhesions?
One explanation of the maturation of Langerhans cells when they leave peripheral tissues and migrate to lymph nodes is their release from E-cadherin-mediated adhesions; 33, 34 this, in turn, may trigger the activation of the b-catenin signalling pathway. 35 Accordingly, we checked if a similar mechanism operated when DCs were released from spleen. However, we saw no staining of spleen DCs with anti-E-cadherin antibodies (clones ECCD-1 and ECCD-2; Zymed Laboratories, San Francisco, CA, USA), despite a number of procedures which should have overcome any loss from the DC surface. These included staining DCs purified by our usual procedure, staining DCs isolated without collagenase digestion, staining DCs isolated without collagenase digestion or contact with EDTA, and staining DCs by adding the anti-E-cadherin antibody to spleen cells before and during these dissociation procedures. In case undetectable levels of E-cadherin were involved, or another adhesion molecule served a similar function, we checked if the b-catenin pathway was involved in the spontaneous activation process by testing spleen DCs lacking b-catenin. Since full ablation of the b-catenin gene causes embryonic death, bone marrow chimeric mice were constructed by reconstituting irradiated mice with bone marrow from conditional knockout mice where the b-catenin gene had been inactivated in adults. 23 Spleens from these reconstituted mice displayed a normal content and distribution of DC subsets (data not shown). Donor type b-catenin null DCs purified from the spleens of such reconstituted mice were then compared with donor type b-catenin expressing spleen DCs from control mice reconstituted with bone marrow from mice in which the b-catenin gene inactivation could not occur. As shown in Figure 4B , the control and the b-catenin null DCs showed identical levels of up-regulation of MHC II and co-stimulator molecules on culture, results similar to normal spleen DCs. Thus, there was no evidence that release from spleen tissue adhesions of this type had initiated the DC activation obtained on subsequent culture.
Do soluble inhibitory factors hold back DC activation?
It was possible the activation of DCs in culture was a result of release from some soluble inhibitory factor present in vivo. We, therefore, tested whether mouse serum, or even fetal calf serum (FCS) used at low levels in the standard culture medium, could inhibit DC activation in culture. Dendritic cells were cultured overnight in medium either lacking serum, or containing various levels of mouse serum or FCS (Fig. 5A) .
No effects were seen on the up-regulation in culture of MHC II, of CD80 or of CD86. However, high concentrations of FCS and moderate concentrations of mouse serum caused partial reduction in the up-regulation of CD40. Hence, it was possible that release from some soluble factor restricting CD40 expression in vivo contributed to CD40 up-regulation in culture. 
Do lymphocytes hold back DC activation?
It was possible that the presence of lymphocytes in the spleen in some way inhibited the DC activation process, so DC isolation followed by incubation in culture provided release from such inhibition. Accordingly, the purified DCs were incubated with the DC-depleted dense fraction of spleen at a ratio of 1 DC to 35 splenocytes, mimicking the situation in the intact spleen. At the end of incubation, the levels of the markers on the CD11c hi gated DCs were determined (Fig. 5B) . Adding in dense spleen cells had no effect on the up-regulation of MHC II, but reduced the up-regulation of CD40, CD80 and CD86. Similar results were obtained when the unseparated digested spleen suspension was incubated at similar concentrations and the DCs isolated after, rather than before, culture (data not shown).
To determine which cells were responsible for the inhibitory effect, the dense spleen cells were depleted of B-cells, of T-cells, or of both; the cells that remained from the initial dense spleen input, now reduced in total number, were then incubated with the purified DCs. The inhibitory effect on co-stimulator molecule up-regulation persisted, regardless of the depleted dense cell preparations used, although the effect was reduced as the total number of dense cells added decreased with depletion of lymphocytes (Fig. 5B ). It appeared that the presence of any spleen cells, rather than any particular cell type, caused the reduction in activation.
MHC II
CD80 CD86 To determine if a soluble product of the spleen cells was responsible for partially inhibiting co-stimulator molecule up-regulation, DCs were incubated either with the supernatant from an overnight culture of spleen cells alone, or incubated in a culture vessel with the spleen cells in an insert separated from the DCs by a 1 mm pore size membrane. This caused little, if any, effect on the co-stimulator molecule up-regulation (data not shown). It was concluded that the spleen cells themselves, rather than their products, were responsible for restricting DC activation in culture.
Do DC-DC interactions cause DC activation in culture?
At the concentration of DCs placed in culture (5 Â 10 6 cells/ml), DCs make contact with each other after settling to the flat-bottomed base of the culture vessels. They then form distinct clusters during culture. It seemed possible that the effect of additional spleen cells in reducing DC activation could simply be in reducing DC-DC interactions, the spleen cells serving as neutral spacers. Accordingly, the potential for DC-DC interaction in culture was reduced by several alternative procedures. One was simply diluting the medium to reduce the DC concentration over 20-fold, then using multiple culture vessels. Another was by including methylcellulose in the medium without changing the volume of the medium; this maintained the DCs in suspension in a semi-solid gel and prevented them clustering together at the bottom of the wells. Another was applying both of these approaches simultaneously. The level of the DC surface markers was determined after recovering and washing the cells.
The manipulations to reduce DC-DC interactions were effective in reducing cluster formation, as determined by inspection using low magnification microscopy (Fig. 6 ). These manipulations produced only a marginal reduction in MHC II up-regulation during culture (Fig. 6 ). However, both reduction in DC concentration and immobilisation of DCs in a semi-solid medium reduced the degree of up-regulation of CD40, CD80 and CD86. Combining the two effects of concentration reduction and immobilisation produced a striking reduction, although not total elimination, of the co-stimulator molecule up-regulation ( Fig. 6 ). Similar effects were seen when collagen, rather than methylcellulose, was used to immobilise DCs during culture. Conversely, the extent of up-regulation of co-stimulatory molecules increased when the probability of DC to DC contact was increased by using V-well, rather than flat-bottom well, culture vessels (data not shown). Importantly, the phenomenon of co-stimulator upregulation depending on probability of DC to DC contact was also obtained when each of the purified spleen DC subtypes was cultured individually. We concluded that homeotypic DC-DC interactions in culture were able to initiate up-regulation of the co-stimulatory molecules.
Can fixed DCs signal DC co-stimulatory molecule up-regulation?
We asked if the DC to DC signals, responsible for part of the up-regulation of the indicator molecules, could be delivered by fixed DCs. Fresh DCs from CD45.1 mice were incubated at low concentration with well washed, paraformaldehyde-fixed DCs from CD45.2 mice, added at high concentration. After culture, the levels of indicator molecules on the non-fixed CD45.1 þ DCs were determined (Fig. 7) . The incubation of the CD45.1 þ DCs alone at low cell concentration gave 6 . The effect of reducing DC concentration or of immobilising DCs in semi-solid media on the up-regulation of marker molecules on culture. Three such experiments using the total cDC population gave similar results. In addition, in a separate experiment using isolated cDC subsets, each subset gave a similar result. Similar results were also obtained when collagen rather than methylcellulose was used to immobilise the DCs in culture.
results similar to those in Figure 6 , namely normal up-regulation of MHC II but reduced up-regulation of CD40, CD80 and CD86. The addition of a high concentration of fixed CD45.2 þ DCs did not allow the CD45.1 þ DCs to attain the full co-stimulatory molecule up-regulation. Rather, a reduced degree of up-regulation was obtained, below that normally obtained by diluted culture alone. This included some reduction in MHC II up-regulation. Thus, the fixed DCs behaved like the splenocytes of Figure 5B , apparently acting as neutral spacers restricting unfixed DCs to unfixed DC interactions. We concluded the DC-DC interaction producing indicator molecule up-regulation was an active process requiring viable DCs to deliver the activation signals.
Does DC-DC interaction produce soluble factors activating DCs?
Since an active process was involved in the DC-DC interactions, we asked if soluble factors were produced which caused or enhanced the final indicator molecule up-regulation. Supernatants were collected from cultures of purified DCs incubated at high cell concentrations. These were tested for their ability to induce indicator molecule up-regulation when added to cultures of DCs incubated at low cell concentrations (Fig. 8 ).
The addition of the culture supernatants from high concentration DC cultures to low concentration DC cultures produced a level of co-stimulatory molecule up-regulation equal to, and in the case of CD80 and CD86, even a little higher than that normally obtained from high concentration DC cultures. We concluded DC-DC interactions produce soluble factors that then mediate or enhance DC surface co-stimulatory molecule up-regulation. concentration cultures. The activity was partially inactivated at 80 C and fully inactivated at 100 C. Based on passage through Centricon (Amicon Inc., Beverly, MA, USA) membranes of graded pore size, the active factors appeared to be mainly in the 50,000 to 100,000 molecular mass range. A series of tests using specific blocking antibodies against cytokines were run to see if the activity in the supernatant could be identified, but none tested gave more than a minor drop in activity. The supernatants caused up-regulation of co-stimulator molecules in DCs from the IFN-a receptor null mice, indicating that type 1 interferons binding to these receptors were not responsible. The small volumes of supernatant produced and the limited number of DCs that could be purified restricted further characterisation.
DISCUSSION
The apparently spontaneous activation of lymphoid tissue DCs when they are isolated and placed in culture has been a puzzling phenomenon. It is not just a normal continuation of a maturation progression that occurs in vivo during the 3-day life-span of spleen DCs, 36 since virtually all freshly isolated spleen DCs are found in an immature or non-activated state, whereas by 12 h extensive activation has occurred in culture. Something must initiate the activation process. Several different types of explanation have been considered, although few have been tested experimentally. One common explanation is that the damage or stress of the isolation procedure causes DC activation. 37 We have excluded some possible sources of such damage, such as the digestion with collagenase or cell sorting, since the up-regulation of the markers occurs even when these steps are avoided. Damage during isolation can also be excluded as the cause of the marked upregulation of co-stimulator molecules, since we have found culture conditions where this does not occur even though the isolation conditions are unchanged. Another common explanation is that activation is caused by contaminating microbial products. This now seems unlikely, since we found the activation occurs in simple media lacking serum and occurs with mutant DCs unable to respond to common microbial products such as endotoxin. It is more likely the activation process reflects a normal DC physiological response to the changed conditions.
One hypothesis is that the activation in culture is a normal progression that occurs when the DCs are released from a factor in vivo that holds the DCs in an immature state. The activation or maturation of Langerhans cells or certain culture-derived DCs when released from E-cadherin-mediated binding seemed a good model of such an effect. 35 However, we found no evidence that E-cadherin was involved in DC-to-DC adhesions in the spleen. Nor did the signalling steps involved seem similar to those involved in Langerhans cell activation, since spleen DC activation in culture occurred in the absence of b-catenin. An alternative version of this hypothesis is that soluble factors, such as the anti-inflammatory cytokines transforming growth factor (TGF)-b or IL-10, might serve to restrict DC activation in vivo. We obtained evidence that a factor in mouse serum, and present at lower levels in FCS, is able to restrict CD40 up-regulation, but not other aspects of DC activation in culture. Thus, release from in vivo inhibitions may have been a contributing factor, but did not explain most of the DC activation events we observed on culture.
Normal autocrine production of cytokines such as type I interferons by the DCs, or enhanced production due to the stresses of isolation, have been suggested as contributing to the spontaneous activation. 31 In our study, where the major type I interferon producing plasmacytoid cells had been removed, type I interferons acting via the IFN-a receptors 1 or 2 do not seem to be the initiating factor, although they did affect the actual levels of marker molecules attained. One study indicated that IL-12 (measured as IL-12p40) and TNF-a are produced by DCs undergoing spontaneous activation in culture. 37 In our hands, isolated DCs when placed in culture do not produce bioactive IL-12p70 unless a microbial stimulus and other cytokines are present. 17 In separate experiments (unpublished), we found blocking antibodies against TNF-a had no effect on the upregulation of the marker molecules in culture. However, we did find that other soluble factors produced by the DCs themselves are involved.
Our major finding is that most of the up-regulation of co-stimulatory molecules that occurs when DCs are isolated and placed in culture is the end result of a positive stimulatory signal, but one given by the DCs themselves, DCs are equipped to transmit stimulatory signals to interacting cells, generally to T-cells. When DCs are concentrated together in culture, they form clusters or aggregates, indicating there is close contact and adhesions. We now find this contact initiates DC activation even when only a single DC subtype is present in culture. This, in turn, leads to the production of soluble factors, as yet not identified. These factors cause or enhance the up-regulation of CD86, CD80 and CD40. The main evidence we found for this 'group grope' hypothesis is that up-regulation of co-stimulatory molecules is markedly reduced by culture conditions which minimise DC to DC interactions; these include reducing the DC concentration, increasing the surface area at the base of the culture vessel, immobilising DCs so they cannot settle together although the culture volume remains constant, and providing other cells as spacers.
In addition, the supernatant from high DC concentration cultures is able to enhance up-regulation of co-stimulator molecules on DCs in low DC concentration cultures. Thus, in our view, autocrine production of soluble factors does contribute to the DC activation, but it is initiated or enhanced by DC-DC interactions.
What are the implications of this mode of DC activation? We suggest it is primarily a culture artefact, occurring only when DCs are artificially clustered together. In the spleen itself, the DCs are spaced out, with other cells including T-cells intervening; our experiments show that, even in culture, lymphocytes can act as neutral spacers, reducing the activation resulting from DC-to-DC interactions. This also implies that the spontaneous activation of DCs in culture where a few DCs are used to activate many T-cells is less of a complicating factor than previously feared, since the DCs will be partially separated from each other by the intervening T-cells.
We must emphasise that not all aspects of DC activation in culture are fully explained by this selfactivation model. Somewhat different rules appear to govern the up-regulation of each marker. Thus, mouse serum appeared to constrain only the up-regulation of CD40. Strikingly, the increase in MHC II surface levels on the DCs in culture usually persisted despite manipulations which greatly reduced the up-regulation of other markers. Occasionally, a slight reduction in the MHC II level attained was observed. This might simply indicate a much higher sensitivity to the same signals that increased co-stimulator molecule expression. The presence of a substantial reservoir of MHC II within the immature DCs prior to culture might explain why, even under conditions of reduced DC-DC interaction, a full complement of MHC II appears on the DC surface The requirement for protein synthesis for even MHC II up-regulation would then reflect the synthesis of the soluble factors which signal surface marker up-regulation in this two-step process. Despite this uncertainty regarding MHC II, we do now have a clear explanation for one aspect of DC activation in culture; it appears to be self-induced, rather than spontaneous.
